-
公开(公告)号:EP3626829A1
公开(公告)日:2020-03-25
申请号:EP18802093.7
申请日:2018-05-17
IPC分类号: C12Q1/06 , C12N1/20 , G01N33/68 , G01N33/92 , C12Q1/6851
摘要: The present invention relates to a method for simply diagnosing the progress of disease condition of a Parkinson's disease patient. Provided are a method for determining Parkinson's disease using the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria as a marker, and a method for determining Parkinson's disease using the blood LPS level and/or the blood LBP level of a Parkinson's disease patient as an indicator.
-
公开(公告)号:EP3369814A1
公开(公告)日:2018-09-05
申请号:EP16859981.9
申请日:2016-10-28
发明人: TSUJI, Hirokazu , MORIYAMA, Kaoru , NOMOTO, Koji
摘要: The present invention provides a method for determining whether a test subject has equol-producing ability or not. A method for measuring equol-producing ability of a test subject, wherein an equol converting enzyme gene derived from enteric bacteria of a test subject is detected using three types of primer sets set forth in the following a) to c): a) a primer pair comprising an oligonucleotide having a base sequence represented by SEQ ID NO: 1 and an oligonucleotide having a base sequence represented by SEQ ID NO: 2, or a primer pair comprising complementary sequences corresponding to said base sequences, b) a primer pair comprising an oligonucleotide having a base sequence represented by SEQ ID NO: 3 and an oligonucleotide having a base sequence represented by SEQ ID NO: 4, or a primer pair comprising complementary sequences corresponding to said base sequences, c) a primer pair comprising an oligonucleotide having a base sequence represented by SEQ ID NO: 5 and an oligonucleotide having a base sequence represented by SEQ ID NO: 6 or 7, or a primer pair comprising complementary sequences corresponding to said base sequences.
-
公开(公告)号:EP2402429B1
公开(公告)日:2017-09-13
申请号:EP10745988.5
申请日:2010-02-25
IPC分类号: A23L33/105
CPC分类号: C12R1/01 , A23L33/105 , A61K31/7048 , A61K35/74 , C12P17/06
摘要: The present invention is directed to a microorganism having an ability of converting daidzein to equol in 24 hours of 50% or higher; a food/beverage or pharmaceutical composition containing the microorganism; an equol production method employing the microorganism; and a nucleic acid fragment which can specifically detect the microorganism.
摘要翻译: 本发明涉及具有在24小时内将黄豆苷原转化为雌马酚的能力为50%或更高的微生物; 含有微生物的食物/饮料或药物组合物; 采用该微生物的雌马酚生产方法; 和可以特异性检测微生物的核酸片段。
-
4.
公开(公告)号:EP4306959A3
公开(公告)日:2024-03-27
申请号:EP23210551.0
申请日:2018-05-17
申请人: Kabushiki Kaisha Yakult Honsha , National University Corporation Tokai National Higher Education and Research System
IPC分类号: C12Q1/06 , C12N1/20 , G01N33/68 , G01N33/92 , C12Q1/6851 , C12Q1/10 , C12Q1/689 , G01N33/569
摘要: The present invention relates to a method for simply diagnosing the progress of disease condition of a Parkinson's disease patient. Provided are a method for determining Parkinson's disease using the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria as a marker, and a method for determining Parkinson's disease using the blood LPS level and/or the blood LBP level of a Parkinson's disease patient as an indicator.
-
5.
公开(公告)号:EP4306959A2
公开(公告)日:2024-01-17
申请号:EP23210551.0
申请日:2018-05-17
申请人: Kabushiki Kaisha Yakult Honsha , National University Corporation Tokai National Higher Education and Research System
IPC分类号: G01N33/569
摘要: The present invention relates to a method for simply diagnosing the progress of disease condition of a Parkinson's disease patient. Provided are a method for determining Parkinson's disease using the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria as a marker, and a method for determining Parkinson's disease using the blood LPS level and/or the blood LBP level of a Parkinson's disease patient as an indicator.
-
公开(公告)号:EP1944021B1
公开(公告)日:2014-05-21
申请号:EP06822881.6
申请日:2006-11-02
发明人: TSUJI, Hirokazu , NOMOTO, Koji , AKAZA, Hideyuki
IPC分类号: A61K31/047 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61P5/30 , A61P17/18 , A61P43/00 , C12Q1/02 , A23L1/09 , C12Q1/04 , A23L1/236
CPC分类号: C12Q1/04 , A23L5/00 , A23L21/00 , A23L27/33 , A23L29/30 , A23L29/37 , A23L33/125 , A61K31/047 , A61K31/7004 , A61K31/7016 , A61K31/702
摘要: An object of the invention is to provide a medical drug, a food and drink having a role in regulating the concentration of equol in vivo and being capable of taking for a long time with high safety and provide a selective medium for a microorganism having conversion ability to equol and a method of detecting the same. Provided are an equol concentration-raising or reducing agent containing a carbohydrate as an active ingredient; use of a carbohydrate for producing the equol concentration-raising or reducing agent; a method of raising or reducing the concentration of equol by administrating a carbohydrate in an effective dose; a selective medium containing a carbohydrate for a microorganism having conversion ability to equol; and a method of detecting a microorganism having conversion ability to equol by use of the selective medium.
-
公开(公告)号:EP2402429A1
公开(公告)日:2012-01-04
申请号:EP10745988.5
申请日:2010-02-25
IPC分类号: C12N1/20 , A23L1/30 , A61K31/7048 , A61K35/74 , A61K47/10 , A61K47/20 , C12N15/09 , C12P17/06 , C12R1/01
CPC分类号: C12R1/01 , A23L33/105 , A61K31/7048 , A61K35/74 , C12P17/06
摘要: The present invention is directed to a microorganism having an ability of converting daidzein to equol in 24 hours of 50% or higher; a food/beverage or pharmaceutical composition containing the microorganism; an equol production method employing the microorganism; and a nucleic acid fragment which can specifically detect the microorganism.
-
公开(公告)号:EP1944021A1
公开(公告)日:2008-07-16
申请号:EP06822881.6
申请日:2006-11-02
发明人: TSUJI, Hirokazu , NOMOTO, Koji , AKAZA, Hideyuki
IPC分类号: A61K31/047 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61P5/30 , A61P17/18 , A61P43/00 , C12Q1/02
CPC分类号: C12Q1/04 , A23L5/00 , A23L21/00 , A23L27/33 , A23L29/30 , A23L29/37 , A23L33/125 , A61K31/047 , A61K31/7004 , A61K31/7016 , A61K31/702
摘要: An object of the invention is to provide a medical drug, a food and drink having a role in regulating the concentration of equol in vivo and being capable of taking for a long time with high safety and provide a selective medium for a microorganism having conversion ability to equol and a method of detecting the same. Provided are an equol concentration-raising or reducing agent containing a carbohydrate as an active ingredient; use of a carbohydrate for producing the equol concentration-raising or reducing agent; a method of raising or reducing the concentration of equol by administrating a carbohydrate in an effective dose; a selective medium containing a carbohydrate for a microorganism having conversion ability to equol; and a method of detecting a microorganism having conversion ability to equol by use of the selective medium.
摘要翻译: 本发明的目的在于提供一种能够在体内调节雌马酚的浓度,能够长时间高安全性地使用的药物,食品和饮料,具有转化能力的微生物的选择性培养基 至雌马酚及其检测方法。 提供含有碳水化合物作为活性成分的雌马酚浓度升高或还原剂; 使用碳水化合物制备雌马酚浓度升高或还原剂; 通过以有效剂量施用碳水化合物来提高或降低雌马酚的浓度的方法; 一种选择性培养基,其含有具有对牛尿酚转化能力的微生物的碳水化合物; 以及通过使用选择培养基检测具有牛尿酚转化能力的微生物的方法。
-
-
-
-
-
-
-